Neuroendocrine Tumor Carcinoid
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor Carcinoid.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Pharmaceutical Management in Targeted Radioligand Therapy
Clinical trial update indicates a study on pharmaceutical management in targeted radioligand therapy is currently recruiting at Hospices Civ…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors [Phase 2]
A Phase 2 study is evaluating daily 5 mg versus 10 mg everolimus in patients with neuroendocrine tumors; the trial is currently recruiting.